{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:40:48Z","timestamp":1779370848538,"version":"3.53.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81702423"],"award-info":[{"award-number":["No. 81702423"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010031","name":"Chinese Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["No. 2017M623442"],"award-info":[{"award-number":["No. 2017M623442"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00520-020-05621-8","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T14:02:43Z","timestamp":1594648963000},"page":"1369-1375","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Asprosin is associated with anorexia and body fat mass in cancer patients"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0213-9199","authenticated-orcid":false,"given":"Cheng","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuxuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baolei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangwei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"5621_CR1","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.ajem.2017.12.032","volume":"36","author":"AC Acara","year":"2018","unstructured":"Acara AC, Bolatkale M, Kiziloglu I, Ibisoglu E, Can C (2018) A novel biochemical marker for predicting the severity of ACS with unstable angina pectoris: asprosin. Am J Emerg Med 36:1504\u20131505","journal-title":"Am J Emerg Med"},{"key":"5621_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/09513590.2018.1512967","volume":"35","author":"M Alan","year":"2019","unstructured":"Alan M, Gurlek B, Yilmaz A, Aksit M, Aslanipour B, Gulhan I, Mehmet C, Taner CE (2019) Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol 35:220\u2013223","journal-title":"Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol"},{"key":"5621_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12891-017-1483-7","volume":"18","author":"SA Alkahtani","year":"2017","unstructured":"Alkahtani SA (2017) A cross-sectional study on sarcopenia using different methods: reference values for healthy Saudi young men. BMC Musculoskelet Disord 18:119","journal-title":"BMC Musculoskelet Disord"},{"key":"5621_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","volume":"15","author":"JM Argiles","year":"2018","unstructured":"Argiles JM, Stemmler B, Lopez-Soriano FJ, Busquets S (2018) Inter-tissue communication in cancer cachexia. Nat Rev Endocrinol 15:9\u201320","journal-title":"Nat Rev Endocrinol"},{"key":"5621_CR5","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.cyto.2012.10.023","volume":"61","author":"ML Batista Jr","year":"2013","unstructured":"Batista ML Jr, Olivan M, Alcantara PS, Sandoval R, Peres SB, Neves RX, Silverio R, Maximiano LF, Otoch JP, Seelaender M (2013) Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients. Cytokine 61:532\u2013539","journal-title":"Cytokine"},{"key":"5621_CR6","first-page":"661","volume":"24","author":"S Blauwhoff-Buskermolen","year":"2016","unstructured":"Blauwhoff-Buskermolen S, Ruijgrok C, Ostelo RW, de Vet HCW, Verheul HMW, de van der Schueren MAE, Langius JAE (2016) The assessment of anorexia in patients with cancer: cut-off values for the FAACT-A\/CS and the VAS for appetite. Suppor Care Cancer Off J Multinatl Assoc Support Care Cancer 24:661\u2013666","journal-title":"Suppor Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"5621_CR7","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.2217\/fon.15.96","volume":"11","author":"P Boura","year":"2015","unstructured":"Boura P, Loukides S, Grapsa D, Achimastos A, Syrigos K (2015) The diverse roles of adiponectin in non-small-cell lung cancer: current data and future perspectives. Future Oncol 11:2193\u20132203","journal-title":"Future Oncol"},{"key":"5621_CR8","doi-asserted-by":"crossref","unstructured":"Ceylan HI, Saygin O (2020) An investigation of the relationship between new fasting hormone asprosin, obesity and acute-chronic exercise: current systematic review. Arch Physiol Biochem:1\u201312","DOI":"10.1080\/13813455.2020.1767652"},{"key":"5621_CR9","doi-asserted-by":"crossref","unstructured":"Del Fabbro E (2015) Current and future care of patients with the cancer anorexia-cachexia syndrome American Society of Clinical Oncology educational book American Society of Clinical Oncology Annual Meeting: e229\u2013237","DOI":"10.14694\/EdBook_AM.2015.35.e229"},{"key":"5621_CR10","doi-asserted-by":"publisher","first-page":"619649","DOI":"10.1155\/2014\/619649","volume":"2014","author":"D Diakowska","year":"2014","unstructured":"Diakowska D, Markocka-Maczka K, Szelachowski P, Grabowski K (2014) Serum levels of resistin, adiponectin, and apelin in gastroesophageal cancer patients. Dis Markers 2014:619649","journal-title":"Dis Markers"},{"key":"5621_CR11","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/nm.4432","volume":"23","author":"C Duerrschmid","year":"2017","unstructured":"Duerrschmid C, He Y, Wang C, Li C, Bournat JC, Romere C, Saha PK, Lee ME, Phillips KJ, Jain M, Jia P, Zhao Z, Farias M, Wu Q, Milewicz DM, Sutton VR, Moore DD, Butte NF, Krashes MJ, Xu Y, Chopra AR (2017) Asprosin is a centrally acting orexigenic hormone. Nat Med 23:1444\u20131453","journal-title":"Nat Med"},{"key":"5621_CR12","doi-asserted-by":"publisher","first-page":"287457","DOI":"10.1155\/2012\/287457","volume":"2012","author":"DR Engineer","year":"2012","unstructured":"Engineer DR, Garcia JM (2012) Leptin in anorexia and cachexia syndrome. Int J Pept 2012:287457","journal-title":"Int J Pept"},{"key":"5621_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/jcsm.12059","volume":"6","author":"CC Ezeoke","year":"2015","unstructured":"Ezeoke CC, Morley JE (2015) Pathophysiology of anorexia in the cancer cachexia syndrome. J Cachexia Sarcopenia Muscle 6:287\u2013302","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"5621_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489\u2013495","journal-title":"Lancet Oncol"},{"key":"5621_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s13402-019-00428-0","volume":"42","author":"A Ghasemi","year":"2019","unstructured":"Ghasemi A, Saeidi J, Azimi-Nejad M, Hashemy SI (2019) Leptin-induced signaling pathways in cancer cell migration and invasion. Cell Oncol 42:243\u2013260","journal-title":"Cell Oncol"},{"key":"5621_CR16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nrendo.2016.66","volume":"12","author":"C Greenhill","year":"2016","unstructured":"Greenhill C (2016) Liver: asprosin\u2014new hormone involved in hepatic glucose release. Nat Rev Endocrinol 12:312","journal-title":"Nat Rev Endocrinol"},{"key":"5621_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2337\/dbi19-0009","volume":"69","author":"JG Hoffmann","year":"2020","unstructured":"Hoffmann JG, Xie W, Chopra AR (2020) Energy regulation mechanism and therapeutic potential of asprosin. Diabetes 69:559\u2013566","journal-title":"Diabetes"},{"key":"5621_CR18","first-page":"CD012229","volume":"2","author":"MN Khatib","year":"2018","unstructured":"Khatib MN, Shankar AH, Kirubakaran R, Gaidhane A, Gaidhane S, Simkhada P, Quazi Syed Z (2018) Ghrelin for the management of cachexia associated with cancer. Cochrane Database Syst Rev 2:CD012229","journal-title":"Cochrane Database Syst Rev"},{"key":"5621_CR19","doi-asserted-by":"crossref","unstructured":"Kocaman N, Artas G (2019) Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma? Biotech Histochem Off Publ Biol Stain Comm:1\u20135","DOI":"10.1080\/10520295.2019.1656344"},{"key":"5621_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.21037\/apm.2018.11.01","volume":"8","author":"JS Malik","year":"2019","unstructured":"Malik JS, Yennurajalingam S (2019) Prokinetics and ghrelin for the management of cancer cachexia syndrome. Ann Palliat Med 8:80\u201385","journal-title":"Ann Palliat Med"},{"key":"5621_CR21","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/bjc.2014.379","volume":"111","author":"KA Mirza","year":"2014","unstructured":"Mirza KA, Tisdale MJ (2014) Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle. Br J Cancer 111:903\u2013908","journal-title":"Br J Cancer"},{"key":"5621_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12079-020-00566-3","volume":"14","author":"ML Muthu","year":"2020","unstructured":"Muthu ML, Reinhardt DP (2020) Fibrillin-1 and fibrillin-1-derived asprosin in adipose tissue function and metabolic disorders. J Cell Commun Signal 14:159\u2013173","journal-title":"J Cell Commun Signal"},{"key":"5621_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ctrv.2013.06.005","volume":"40","author":"E Ntikoudi","year":"2014","unstructured":"Ntikoudi E, Kiagia M, Boura P, Syrigos KN (2014) Hormones of adipose tissue and their biologic role in lung cancer. Cancer Treat Rev 40:22\u201330","journal-title":"Cancer Treat Rev"},{"key":"5621_CR24","volume-title":"Cancer, anorexia and cachexia","author":"T Ohnuma","year":"2019","unstructured":"Ohnuma T, Paluri R, Adigun R (2019) Cancer, anorexia and cachexia. StatPearls, Treasure Island"},{"key":"5621_CR25","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1023\/A:1016670403148","volume":"9","author":"JM Ribaudo","year":"2000","unstructured":"Ribaudo JM, Cella D, Hahn EA, Lloyd SR, Tchekmedyian NS, Von Roenn J, Leslie WT (2000) Re-validation and shortening of the Functional Assessment of Anorexia\/Cachexia Therapy (FAACT) questionnaire. Qual Life Res Int J Qual Life Asp Treat Care Rehab 9:1137\u20131146","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehab"},{"key":"5621_CR26","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","volume":"165","author":"C Romere","year":"2016","unstructured":"Romere C, Duerrschmid C, Bournat J, Constable P, Jain M, Xia F, Saha PK, Del Solar M, Zhu B, York B, Sarkar P, Rendon DA, Gaber MW, LeMaire SA, Coselli JS, Milewicz DM, Sutton VR, Butte NF, Moore DD, Chopra AR (2016) Asprosin, a fasting-induced glucogenic protein hormone. Cell 165:566\u2013579","journal-title":"Cell"},{"key":"5621_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.critrevonc.2015.12.008","volume":"99","author":"R Tarricone","year":"2016","unstructured":"Tarricone R, Ricca G, Nyanzi-Wakholi B, Medina-Lara A (2016) Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: A systematic review. Crit Rev Oncol Hematol 99:49\u201362","journal-title":"Crit Rev Oncol Hematol"},{"key":"5621_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ando.2013.03.004","volume":"74","author":"JP Thissen","year":"2013","unstructured":"Thissen JP, Loumaye A (2013) Role of activin A and myostatin in cancer cachexia. Ann Endocrinol 74:79\u201381","journal-title":"Ann Endocrinol"},{"key":"5621_CR29","doi-asserted-by":"publisher","first-page":"2521096","DOI":"10.1155\/2019\/2521096","volume":"2019","author":"K Ugur","year":"2019","unstructured":"Ugur K, Aydin S (2019) Saliva and blood asprosin hormone concentration associated with obesity. Int J Endocrinol 2019:2521096","journal-title":"Int J Endocrinol"},{"key":"5621_CR30","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s41366-018-0248-1","volume":"43","author":"CY Wang","year":"2019","unstructured":"Wang CY, Lin TA, Liu KH, Liao CH, Liu YY, Wu VC, Wen MS, Yeh TS (2019) Serum asprosin levels and bariatric surgery outcomes in obese adults. Int J Obes 43:1019\u20131025","journal-title":"Int J Obes"},{"key":"5621_CR31","first-page":"9471583","volume":"2018","author":"Y Wang","year":"2018","unstructured":"Wang Y, Qu H, Xiong X, Qiu Y, Liao Y, Chen Y, Zheng Y, Zheng H (2018) Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion. Mediat Inflamm 2018:9471583","journal-title":"Mediat Inflamm"},{"key":"5621_CR32","doi-asserted-by":"publisher","first-page":"S280","DOI":"10.21037\/tcr.2017.03.52","volume":"6","author":"JP White","year":"2017","unstructured":"White JP (2017) IL-6, cancer and cachexia: metabolic dysfunction creates the perfect storm. Transl Cancer Res 6:S280\u2013S285","journal-title":"Transl Cancer Res"},{"key":"5621_CR33","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.3389\/fphys.2018.01782","volume":"9","author":"M Wiecek","year":"2018","unstructured":"Wiecek M, Szymura J, Maciejczyk M, Kantorowicz M, Szygula Z (2018) Acute anaerobic exercise affects the secretion of asprosin, irisin, and other cytokines\u2014a comparison between sexes. Front Physiol 9:1782","journal-title":"Front Physiol"},{"key":"5621_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cca.2017.10.034","volume":"489","author":"L Zhang","year":"2019","unstructured":"Zhang L, Chen C, Zhou N, Fu Y, Cheng X (2019) Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride. Clin Chim Acta Int J Clin Chem 489:183\u2013188","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"5621_CR35","doi-asserted-by":"crossref","unstructured":"Zhang X, Jiang H, Ma X, Wu H (2019) Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus. J Diabetes Investig","DOI":"10.1111\/jdi.13148"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05621-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-020-05621-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05621-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T05:25:09Z","timestamp":1696397109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-020-05621-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["5621"],"URL":"https:\/\/doi.org\/10.1007\/s00520-020-05621-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"19 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of General Hospital of Northern Theater Command.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from each participant.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}